540788 Stock Overview
Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers in India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Aspira Pathlab & Diagnostics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹30.06 |
| 52 Week High | ₹49.50 |
| 52 Week Low | ₹22.76 |
| Beta | -0.35 |
| 1 Month Change | -6.70% |
| 3 Month Change | -3.59% |
| 1 Year Change | -4.60% |
| 3 Year Change | 0.54% |
| 5 Year Change | -9.32% |
| Change since IPO | 112.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540788 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -6.8% | -4.1% | -2.5% |
| 1Y | -4.6% | 61.1% | 44.5% |
Return vs Industry: 540788 underperformed the Indian Healthcare industry which returned 65% over the past year.
Return vs Market: 540788 underperformed the Indian Market which returned 45.3% over the past year.
Price Volatility
| 540788 volatility | |
|---|---|
| 540788 Average Weekly Movement | 11.1% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 540788 has not had significant price volatility in the past 3 months.
Volatility Over Time: 540788's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 105 | Pankaj Shah | www.aspiradiagnostics.com |
Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers in India. It offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016.
Aspira Pathlab & Diagnostics Limited Fundamentals Summary
| 540788 fundamental statistics | |
|---|---|
| Market cap | ₹309.41m |
| Earnings (TTM) | -₹24.28m |
| Revenue (TTM) | ₹128.13m |
2.4x
P/S Ratio-12.7x
P/E RatioIs 540788 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540788 income statement (TTM) | |
|---|---|
| Revenue | ₹128.13m |
| Cost of Revenue | ₹93.74m |
| Gross Profit | ₹34.39m |
| Other Expenses | ₹58.67m |
| Earnings | -₹24.28m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.36 |
| Gross Margin | 26.84% |
| Net Profit Margin | -18.95% |
| Debt/Equity Ratio | 26.0% |
How did 540788 perform over the long term?
See historical performance and comparison